Bristol Myers Squibb takes legal action against Biden administration over Medicare drug settlements

Bristol Myers Squibb on Friday took legal action against the Biden administration over Medicare’s brand-new powers to work out drug rates, the 3rd such suit to be submitted versus the program in a matter of days.

The suit, submitted in federal district court in New Jersey, argues the Medicare settlements break the First and Fifth Amendments of the U.S. Constitution.

Bristol Myers Squibb stated its blood thinner Eliquis will go through the settlements this year. Eliquis is utilized to avoid embolism and strokes.

The drugmaker has actually asked the court to state the program unconstitutional and avoid the Health and Human Services Department from requiring the business to get in settlements.

Bristol Myers Squibb’s arguments mirror those lodged by drugmaker Merck recently, which was the very first business to take legal action against the federal government over the drug settlements.

The U.S. Chamber of Commerce has actually likewise taken legal action against HHS over the program with comparable arguments.

This is breaking news. Please examine back for updates.


News and digital media editor, writer, and communications specialist. Passionate about social justice, equity, and wellness. Covering the news, viewing it differently.

Related Articles

Back to top button